An Exploratory Open Trial on Safety and Efficacy of the Anticonvulsant Retigabine in Acute Manic Patients

Benedikt L. Amann; Andrea Sterr; Eduard Vieta; Robert Stampfer; Jörg Walden; Heinz Grunze

doi:10.1097/01.jcp.0000236661.95200.3e

Related publications

Letter2007

A 2-Year, Open-Label Pilot Study of Adjunctive Chromium in Patients With Treatment-Resistant Rapid-Cycling Bipolar Disorder

Benedikt L. Amann, Roland Mergl, Eduard Vieta, Christoph Born, Igor Hermisson, Florian Seemueller, Sandra Dittmann, Heinz Grunze

Letter2009

Response to Shen J, Kobak K, Zhao Y, et al. Use of Remote Centralized Raters Via Live 2-Way Video in a Multicenter Clinical Trial for Schizophrenia. (J Clin Psychopharmacol. 2008;28:691-693)

Heinz Grunze, Cyril Höschl, Stuart Montgomery, Norman Sartorius, Eduard Vieta

Letter2023

Pramipexole as an Augmentation Strategy to Electroconvulsive Therapy in the Treatment of Bipolar Depression Complicated With Parkinsonism

Laura López, A. Bermejo, Marta Bote Gascón, Anna Giménez‐Palomo, Néstor Arbelo, Helena Andreu, Oscar De Juan, Luis Olivier, Lourdes Navarro, Víctor Guerra, Inés Bartolomé, S. Salmerón, Iñaki Ochandiano, Pablo González-Martínez, Miquel Bioque, Lluc Colomer, Gerard Anmella, Cristian-Daniel Llach, Joaquín Gil-Badenes, Antoni Benabarre, Gabriel Pujol-Fontrodona, Eduard Vieta,

Article2008

Efficacy and safety of sorafenib in patients with alcohol-related hepatocellular carcinoma: A sub-analysis from the SHARP trial

Antonio Craxı̀, Camillo Porta, Angelo Sangiovanni, J.F. Seitz, M. Moscovici, Ming Shan, Andrea Nadel, D. Voliotis, Jordi Bruix, Josep M. Llovet

Journal of Clinical Oncology

Article2020

Efficacy and safety of low-dose rivaroxaban on top of aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial

Thomas Vanassche, Peter Verhamme, Darryl P. Leong, Deepak L. Bhatt, Olga Shestakovska, Aldo Maggioni, Keith A.A. Fox, Eva Muehlhofer, Stuart J. Connolly, Salim Yusuf, John W. Eikelboom, Jackie Bosch